NCOA2 and hepatocellular carcinoma: A recent study also demonstrated that low levels of SRC-2 expression in hepatocellular carcinoma patients were associated with poor prognosis, and RNAi-mediated knockdown of NCOA2 in diethylnitrosamine-treated mice promoted liver tumourigenesis [53].